1068 Quality of Life in the Early Period After Allogeneic Hematopoietic Stem Cell Transplantation: Dynamics and the Impact of GVHD Gabriela Lampart 1 , Agnieszka Gniadek 2 , Beata Pitkowska - Jakubas 3 1 Jagiellonian University Medical College, Doctoral School of Medical and Health Sciences, Krakow, Poland, 2 Jagiellonian University Medical College, Faculty of Health Sciences, Institute of Nursing and Midwifery, Krakow, Poland, 3 Jagiellonian University Medical College, Faculty of Medicine, Chair of Hematology, Krakow, Poland Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :1068 Aims Quality of life (QoL) is a crucial aspect of recovery following allogeneic hematopoietic stem cell transplantation (allo-HSCT)
GH injections provide GH directly and can produce different patterns of exposure and side effects
GLP-1, which stands for glucagon-like peptide-1, is a hormone integral to the regulation of appetite and blood sugar control
GLP-1 drugs have not been approved for addiction, and there is not yet enough evidence to prescribe them solely for that purpose